WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s stock price gapped down before the market opened on Monday. The stock had previously closed at $14.30, but opened at $13.76. WuXi Biologics (Cayman) shares last traded at $13.9950, with a volume of 1,382 shares trading hands.
Analyst Ratings Changes
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, WuXi Biologics (Cayman) presently has an average rating of “Hold”.
Get Our Latest Analysis on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Stock Up 3.4%
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.
Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.
See Also
- Five stocks we like better than WuXi Biologics (Cayman)
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
